WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Unveils New Drug Pricing Reform to Balance Innovation, Affordability and... China's State Council General Office has issued a landmark policy document, Several Opinions on Improving the Drug Price Formation Mechanism (Guobanfa [2026] No. 9), sett...
(4/14/2026)

Chinese Biotech Commands One-Third of Global P... (4/21/2026)

China Deepens Opening of Biotech and Healthcar... (4/16/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (4/16/2026)

China's Pharma Innovators Pursue a Range of De... (4/15/2026)

China Private Biotech Funding Slows in Deal Co... (4/15/2026)

PhRMA Warns U.S. Drug Pricing Policies Could A... (4/14/2026)

How Big Pharma's China Trials Are Escaping Scr... (4/13/2026)

China Outbound Biopharma Licensing Surges as G... (4/13/2026)

China Backs Independent Pricing for Innovative... (4/9/2026)

China's Innovative Drug Out-Licensing Surge To... (4/9/2026)

Global Drugmakers Brace for Another Tough Chin... (4/8/2026)

Pharma Bets Big on Chinese Drugmakers (The Wir... (4/7/2026)

Biogen Secures Global Control of Felzart... (4/21/2026) Immorna Reports Breakthru In Vivo CAR-T ... (4/21/2026) China Seeks Feedback on ICH M8 eCTD v4.0... (4/20/2026) China CDE Issues New Technical Guideline... (4/20/2026) China Releases 104th Batch of Reference ... (4/20/2026) China Seeks Public Input on New GSP Appe... (4/20/2026) Santen Acquires China Rights to Five Abb... (4/20/2026) China Private Biotech Financing Shifts T... (4/20/2026) Junshi Reports Strong Early Activity of ... (4/20/2026) Junshi Reports Early High Response Rates... (4/20/2026) Merck to Present First-in-Human Data for... (4/20/2026) Xcovery and EVERSANA Partner to Accelera... (4/20/2026) China's Next Leap in Biopharma Innovatio... (4/20/2026) Recent Official and Executive Moves (4/16/2026) China Poised to Trigger Global Price War... (4/16/2026) China Moves Toward Value-Based Drug Pric... (4/16/2026) CSPC Pharma's Tissue Factor ADC SYS6051 ... (4/16/2026) Aligos Signs Up to US$445M China HBV Dea... (4/16/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

Biogen Secures Global Control of Felzartamab with Great... China's Next Leap in Biopharma Innovation: BCG Xcovery and EVERSANA Partner to Accelerate U.S. Commerc... China Private Biotech Financing Shifts Toward Fewer, La... Santen Acquires China Rights to Five AbbVie Glaucoma Dr...

China Seeks Public Input on New GSP Appendix for Retail... China Releases 104th Batch of Reference Formulations fo... China CDE Issues New Technical Guidelines for IND-Enabl... China Seeks Feedback on ICH M8 eCTD v4.0 Implementation... China CDE Opens Consultation on Draft CMC Guideline for...

China Launches Nationwide Mental Health Coverage Push W... China Moves to Strengthen Community Healthcare and Expa... China Unveils Sweeping Measures to Accelerate Tiered He... NHSA Launches First Public Disclosure for Reference Dru... China Tightens Health Insurance Fund Oversight With New...

Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan... Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa...

India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac...

Immorna Reports Breakthru In Vivo CAR-T Data Showing De... Merck to Present First-in-Human Data for China-Origin P... Junshi Reports Early High Response Rates for PD-1×VEGF... Junshi Reports Strong Early Activity of PD-1×VEGF Bisp... ArkBio Advances Global Influenza Ambitions as AK0406 Be...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Former Sinopharm Chairman Wei Yulin Sentenced to 12 Yea... Recent Official and Executive Moves Former NMPA Chief Bi Jingquan Formally Prosecuted in Br... Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...